medigraphic.com
SPANISH

MEDICC Review

ISSN 1527-3172 (Electronic)
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2022, Number 3-4

<< Back Next >>

MEDICC Review 2022; 24 (3-4)

Insights from Cuba’s COVID-19 Vaccine Enterprise: Report from a High-Level Fact-Finding Delegation to Cuba. Technical Report

Full text How to cite this article

Language: English
References: 0
Page:
PDF size: 760.57 Kb.


Key words:

No keywords

Text Extraction

In June 2022 an international delegation of scientists from the United States, the Caribbean and Africa traveled to Havana, Cuba for a three-day fact-finding mission to better understand Cuba’s COVID-19 vaccine development and vaccination efforts. The delegation was comprised of experts in public health, infectious diseases, biotechnology, and vaccine research and development. The purpose of the fact-finding mission was three-fold: first, to learn how and why a relatively small country of some 11 million people—one facing considerable economic hardships—chose to develop, manufacture and deploy its own vaccines; second, to understand the country’s strategy for vaccine rollout and its preliminary results; and third, to explore Cuba’s approach to science in the context of public health, with implications for what a safe, effective Cuban vaccine might have for COVID-19 vaccine equity— particularly for the most vulnerable in the Global South.





2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

MEDICC Review. 2022;24